A study published in the Endocrine Journal showed some GLP-1 drugs have been linked to an increased risk of developing blood clots
Conversely, inhibitors of PD-1/PD-L1 can selectively attach to either PD-1 or PD-L1, thereby interfering with the PD-1/PD-L1 interaction
PlexusDx and the semaglutide pathway PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, including Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral
Available In-Clinic & Mobile $199-$398 Provides high concentrations of vitamin C to promote antioxidant activity and cellular health
Molecular Formula: CHCuNO (GHK copper complex)
Findings: RCTSemaglutide vs Placebo for Alcohol Use Disorder in Adults, JAMA Psychiatry (2025) [PubMed abstract] Design: Randomized, placebo-controlled trial (N=48 | length = 9 weeks) in non-treatment-seeking adults with alcohol use disorder Treatment: Semaglutide (0.25 mg/week for 4 weeks, 0.5 mg/week for 4 weeks, and 1.0 mg for 1 week) vs Placebo Primary outcome: Objective alcohol self-administration (at baseline and between Weeks 8 and 9) measured as follows: a standardized procedure was used to estimate voluntary alcohol consumption and ability to delay drinking
